Zhiwei is a high-tech company specialized in artificial intelligence(AI)-aided morphological examination and pathological diagnosis. We insist on independent technological innovation and have a large number of related patents and software copyrights. The AI-aided bone marrow cell morphology analysis and diagnosis system developed by Zhiwei, is able to automatically generate digital smears by scanning traditional bone marrow aspirate smears and digitally store all information of the smears. Nucleated cells on scanned bone marrow smears will be located and classified by AI cell recognition algorithm independently developed by Zhiwei and the classification results can help with pathological diagnosis. It is a world leading device in the area of bone marrow cell morphology analysis. Zhiwei enters the field of cytopathology by automatic bone marrow cell morphology examination, which is the most difficult one among all morphology exams, therefore, expanding into peripheral blood and other body fluids examinations such as urine, pleuroperitoneal fluids, cerebrospinal fluids, pericardial effusion will be rapid. Currently great progress has been made in peripheral blood cell morphology and urinary cytology. Zhiwei adheres to the concept of “By serendipity we begin, towards perpetuity we persist” and has attracted many talents from China and abroad. Currently, we have set up professional R&D, academic, registration and marketing teams to create a new medical environment driven by the concept of “to revolutionize traditional medical examination with artificial intelligence”.
By serendipity we begin, towards perpetuity we persist.
Our Vision: Make diagnosis more precise.
Our Mission: Revolutionize medical examination with artificial intelligence.
Our Value: Care for life with technology.
2016.4 Received the golden key award in the “2016 Entrepreneur Pioneer Camp” hosted by the Future Technology City Management Committee, and favored by multiple investing groups that attended
2018.8.4 Won the second place in the growth star award in final of Hangzhou division of China Medical Big Data Industry Innovation Competition
2018.11.14 Awarded outstanding enterprise in the national final of biomedical industry of the 7th China Innovation and Entrepreneurship Competition
2018.8.17 Won the growing enterprise group award in the Zhejiang industry final of the 7th China Innovation and Entrepreneurship Competition
2018.9.8 Won the third place in the growing star award in national final of China Medical Big Data Industry Innovation Competition
2020.12.17 Ping An Technology Innovation Center-China Expansion Program Cohort 5 D-day was held successfully.ZHIWEIXINKE show the achievement